Nasal Drug Delivery Market
Global Nasal Drug Delivery Market Size, Share & Trends Analysis Report by Dosage Form (Gels, Sprays, Drops and Liquids, and Others), by Containers (Non-Pressurized Containers, and Pressurized Containers), by Therapeutic Application (Rhinitis, Nasal Congestion, Asthma, and Others) and by End-User (Hospitals, and Home Health Care) Forecast Period (2022-2028)
The global nasal drug delivery market is anticipated to grow at a significant CAGR of 5.5% during the forecast period. As people across the globe are more aware of the new technologies being implemented in every market and are also adopting new technologies to daily life the coupled with it smart devices for asthma and chronic obstructive pulmonary diseases are more in demand. Moreover, the availability of this device is also been rising and this is useful in tracking patients at each stage. For instance, in October 2021, BreatheSuite, Metered-Dose Inhaler V1 device has cleared FDA 501(k) approval; this device turns existing inhalers into smart inhalers for people with asthma and COPD. It provides feedback on inhaler adherence and technique and it works with a mobile app to evaluate and score a person's inhaler technique and usage patterns. This new smart device is based on technology used with sensors Bluetooth and other dives that monitors patients at every second and are more in demand due to features associated with it, attributed to such factors the nasal drug delivery market is witnessing a positive growth.
However, dry powder inhalers and metered dose inhalers have their efficacy and deliver accurate formulation and also people are unaware of nasal drug delivery devices, and also improper use by patients is hindering the market growth.
Impact of COVID-19 Pandemic on Global Nasal Drug Delivery Market
Due to COVID-19, the nasal drug delivery market witnessed positive growth in the market attributed to the use of the nasal drug in the treatment of COVID-19. Additionally, nasal sprays provide efficacy in the prevention of COVID-19 coupled with its efficacy the demand for these devices was increased among the hospital professionals and patient pool to recover fast. Moreover, new drug delivery devices and techniques were introduced and launched in COVID-19 to recover by key players operating the market. For instance, in February 2022, Aptar Pharma launched HeroTracker Sense's novel digital respiratory health solution which is capable of transforming a standard metered dose inhaler (pMDI) into a smart connected healthcare device. This new device is designed to help improve the lives of patients across the globe from chronic respiratory diseases such as asthma, COPD, Cystic Fibrosis, and other respiratory conditions caused by COVID-19.
Segmental Outlook
The nasal drug delivery is segmented on the basis of dosage form, containers, therapeutic application, and, end-user. Based on dosage form, the market is segmented into gels, sprays, drops and liquids, and others. On the basis of containers, the market is sub-divided into non-pressurized containers and pressurized containers. On the basis of therapeutic application, the market is sub-divided rhinitis, nasal congestion, asthma, and others. Furthermore, based on end-user, the market is sub-classified into hospitals and home health care. Among the therapeutic segment, the asthma segment is holding a prominent share due to the increased number of cases of asthma across the globe coupled with the demand for nasal drug delivery devices and systems is been increased, which in turn drives the growth of the market.
Global Nasal Drug Delivery Market Share by Dosage Form, 2021 (%)
The Drops and Liquid Segment is Dominating the Global Nasal Drug Delivery Market
Based on form, drops and liquids segment is expected to dominate in the market attributed to affordability and the treatment offered by this is more successful. Moreover, drop and liquid are more frequently used in nasal drug delivery and these drugs are an emerging class of medication by their benefits offered to them. These drugs are non-invasive and easy to use in comparison with injectables and this has stability, lower risk of microbial spoilage and among others. Additionally, the increasing demand for self-administration and also growing patient compliance is expected to propel the market growth. Furthermore, the availability of several nasal drops and liquids, are factors that are contributing to the market growth.
Regional Outlooks
The global nasal drug delivery market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East &Africa, and Latin America. North America is estimated to be the dominating region in the global nasal drug delivery market owing to the well-established healthcare infrastructure in the region.
Global Nasal Drug Delivery Market Growth, by Region 2022-2028
The Asia Pacific Region is Fastest Growing in the Global Nasal Drug Delivery market
The Asia Pacific is anticipated to augment the fastest growth in the market due to available effective treatment methods, and rising disposable income. Moreover, with increased urbanization and the high demand for clinical needs and also in the population the awareness regarding the technologically advanced product is been increased. Furthermore, the adoption of inhelor in the region is high due to a high asthmatic population, and also the government in the Asia Pacific in intervals implements awareness campaigns regarding tobacco smoke, and air pollution that causes asthma, and also to grow the adoption of inhalers in the region campaigns are derived. In the region, biopharma companies are increasing and the companies are also making huge investments to introduce new and innovative technologies. For instance, in February 2022, Glenmark pharmaceuticals in partnership with SaNOtize Research & Development Corp, launched a nasal spray in India to ensure and give better treatment for adult patients suffering from Covid-19. The newly launched FabiSpray solution has cleared approval by the Drugs Controller General of India (DCGI) and is available across all retail pharmacies.
Market Players Outlook
The competitive landscape includes key strategies of leading players, recent developments, and key company analysis. The major players that contribute to the growth of the market include 3M Co., APTARGROUP INC., AstraZeneca, Becton Dickinson and Co., Johnson & Johnson Service Inc., Merck KGaA, Novartis International AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Catalent expanded its nasal capabilities at its Morrisville, Research Triangle Park (RTP) in North Carolina. This expansion is mainly to expand and modernize its nasal drug delivery capabilities, substantially increasing technology and capacity. Moreover, it is for the nose-to-brain drug administration, and as an alternative route for the delivery of systemic drugs, and provides several services for the development and manufacturing of unit and bi-dose nasal spray products.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global nasal drug delivery market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Nasal Drug Delivery Market
• Recovery Scenario of Global Nasal Drug Delivery Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. 3M Co.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. APTARGROUP, INC.,
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. AstraZeneca
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Becton, Dickinson and Co.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Merck KGaA
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Nasal Drug Delivery Market by Dosage Form
4.1.1. Gels
4.1.2. Sprays
4.1.3. Drops and Liquids
4.1.4. Other (Powders)
4.2. Global Nasal Drug Delivery Market by Containers
4.2.1. Non-Pressurized Containers
4.2.2. Pressurized Containers
4.3. Global Nasal Drug Delivery Market by Therapeutic Application
4.3.1. Rhinitis
4.3.2. Nasal Congestion
4.3.3. Asthma
4.3.4. Others (Vaccination)
4.4. Global Nasal Drug Delivery Market by End-User
4.4.1. Hospitals
4.4.2. Home Health Care
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Consort Medical plc
6.2. DTR Medical Ltd.
6.3. Glenmark Pharmaceuticals Ltd.
6.4. GlaxoSmithKline plc.
6.5. GoFire, Inc
6.6. Herantis Pharma Plc
6.7. Hikma Pharmaceuticals PLC
6.8. H&T Presspart Manufacturing Ltd.
6.9. Johnson & Johnson Services, Inc.
6.10. Nanoform Finland Oyj
6.11. Nemera Services
6.12. Neurelis, Inc.
6.13. Novartis International AG
6.14. Olympus Corp.
6.15. Pfizer Inc.
6.16. Premier Inc.
6.17. Sanofi S.A
6.18. Summit Medical LLC
6.19. Teleflex Inc.
6.20. Teva Pharmaceutical Industries Ltd.
6.21. Vectura Group Ltd
1. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
2. GLOBAL GELS NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL SPRAY NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)
4. GLOBAL DROPS AND LIQUIDS NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)
5. GLOBAL OTHERS NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)
6. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
7. GLOBAL NASAL DRUG DELIVERY BY NON-PRESSURIZED CONTAINERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL NASAL DRUG DELIVERY BY PRESSURIZED CONTAINERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
10. GLOBAL NASAL DRUG DELIVERY IN RHINITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL NASAL DRUG DELIVERY IN NASAL CONGESTION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL NASAL DRUG DELIVERY IN ASTHMA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL NASAL DRUG DELIVERY IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
15. GLOBAL NASAL DRUG DELIVERY FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL NASAL DRUG DELIVERY FOR HOME HEALTH CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
19. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
20. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
21. NORTH AMERICAN NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
22. EUROPEAN NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. EUROPEAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
24. EUROPEAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
25. EUROPEAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
26. EUROPEAN NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
28. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
29. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
30. ASIA-PACIFIC NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
31. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
32. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
33. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORMS, 2021-2028 ($ MILLION)
34. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
35. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION,2021-2028 ($ MILLION)
36. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER,2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL NASAL DRUG DELIVERY MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL NASAL DRUG DELIVERY MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL NASAL DRUG DELIVERY MARKET, 2021-2028 (%)
4. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY DOSAGE FORM, 2021 VS 2028 (%)
5. GLOBAL GELS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL SPRAYS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL DROPS AND LIQUIDS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL OTHERS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY CONTAINERS, 2021 VS 2028 (%)
10. GLOBAL NASAL DRUG DELIVERY BY NON-PRESSURIZED CONTAINERS MARKET SHARE BY CONTAINERS, 2021 VS 2028 (%)
11. GLOBAL NASAL DRUG DELIVERY BY PRESSURIZED CONTAINERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY THERAPEUTIC APPLICATION, 2021 VS 2028 (%)
13. GLOBAL NASAL DRUG DELIVERY IN RHINITIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL NASAL DRUG DELIVERY IN NASAL CONGESTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL NASAL DRUG DELIVERY IN ASTHMA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL NASAL DRUG DELIVERY IN OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY END-USER, 2021 VS 2028 (%)
18. GLOBAL NASAL DRUG DELIVERY FOR HOSPITALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. GLOBAL NASAL DRUG DELIVERY FOR HOME HEALTH CARE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20. US NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
21. CANADA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
22. UK NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
23. FRANCE NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
24. GERMANY NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
25. ITALY NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
26. SPAIN NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF EUROPE NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
28. INDIA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
29. CHINA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
30. JAPAN NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
31. SOUTH KOREA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
32. REST OF ASIA-PACIFIC NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
33. REST OF THE WORLD NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
